{"id":19180,"date":"2021-11-26T08:58:48","date_gmt":"2021-11-26T07:58:48","guid":{"rendered":"https:\/\/idibell.cat\/es\/?p=19180"},"modified":"2021-11-26T08:59:11","modified_gmt":"2021-11-26T07:59:11","slug":"la-spin-off-salida-del-idibell-aptadel-seleccionada-para-formar-parte-de-bcn-health-booster","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2021\/11\/la-spin-off-salida-del-idibell-aptadel-seleccionada-para-formar-parte-de-bcn-health-booster\/","title":{"rendered":"La spin-off salida del IDIBELL Aptadel seleccionada para formar parte de BCN Health Booster"},"content":{"rendered":"<p>Aptadel forma parte de la primera generaci\u00f3n de empresas aceleradas en la <strong>BCN Health Booster<\/strong>, una iniciativa impulsada por el Parc Cient\u00edfic de Barcelona (PCB) de la Universidad de Barcelona (UB) y el Ayuntamiento de Barcelona, con la colaboraci\u00f3n de Barcelona Activa y el apoyo de Biocat. El proyecto nace en el contexto del Pla Barcelona Ci\u00e8ncia, como ejemplo de la colaboraci\u00f3n y el consenso entre centros p\u00fablicos, empresas, universidades y administraciones para promover la innovaci\u00f3n en salud y el retorno a la sociedad de la inversi\u00f3n en investigaci\u00f3n.<\/p>\n<p>Once empresas innovadoras y de alto impacto social podr\u00e1n participar en un nuevo programa de crecimiento empresarial y tendr\u00e1n acceso bonificado al nuevo laboratorio del PCB durante tres a\u00f1os en el marco de la nueva aceleradora <a href=\"https:\/\/www.pcb.ub.edu\/es\/bcn-health-booster\/\">BCN Health Booster<\/a>.<\/p>\n<p>A la hora de elegir a estas empresas, el comit\u00e9 de expertas ha valorado especialmente a aquellas con mejores perspectivas de viabilidad t\u00e9cnica y econ\u00f3mica, un equipo promotor con experiencia y con posibilidad de impacto social, priorizando las spin-offs de centros de investigaci\u00f3n, hospitales y universidades.<\/p>\n<p><a href=\"https:\/\/www.linkedin.com\/company\/aptadel-therapeutics\/\">Aptadel Therapeutics<\/a> es una empresa precl\u00ednica cofundada por el IDIBELL enfocada a desarrollar una nueva plataforma de terapia dirigida contra el c\u00e1ncer. Esta plataforma consiste en nanopart\u00edculas cargadas con agentes terap\u00e9uticos, como pueden ser mol\u00e9culas de ARN o f\u00e1rmacos quimioter\u00e1picos, dirigidas a diferentes tumores diana. De esta manera los agentes terap\u00e9uticos son liberados all\u00ed donde hace falta, evitando as\u00ed efectos secundarios y mejorando la efectividad de las terapias.<\/p>\n<p>&nbsp;<\/p>\n<p><em>El Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (IDIBELL) es un centro de investigaci\u00f3n en biomedicina creado en 2004. Est\u00e1 participado por el Hospital Universitario de Bellvitge y el Hospital de Viladecans del Instituto Catal\u00e1n de la Salud, el Instituto Catal\u00e1n de Oncolog\u00eda, la Universidad de Barcelona y el Ayuntamiento de L&#8217;Hospitalet de Llobregat.<\/em><\/p>\n<p><em>El IDIBELL es miembro del Campus de Excelencia Internacional de la Universidad de Barcelona HUBc y forma parte de la instituci\u00f3n CERCA de la Generalitat de Catalunya. En 2009 se convirti\u00f3 en uno de los cinco primeros centros de investigaci\u00f3n espa\u00f1oles acreditados como instituto de investigaci\u00f3n sanitaria por el Instituto de Salud Carlos III. Adem\u00e1s, forma parte del programa \u00abHR Excellence in Research\u00bb de la Uni\u00f3n Europea y es miembro de EATRIS y REGIC. Desde el a\u00f1o 2018, IDIBELL es un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>Noticia adaptade del PCR (<a href=\"https:\/\/www.pcb.ub.edu\/es\/arranca-la-aceleradora-bcn-health-booster-con-once-proyectos-empresariales-de-innovacion-en-salud\/\">enlace<\/a>)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aptadel forma parte de la primera generaci\u00f3n de empresas aceleradas en la BCN Health Booster, una iniciativa impulsada por el Parc Cient\u00edfic de Barcelona (PCB) de la Universidad de Barcelona (UB) y el Ayuntamiento de Barcelona, con la colaboraci\u00f3n de Barcelona Activa y el apoyo de Biocat.<\/p>\n","protected":false},"author":8,"featured_media":19181,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[184,374,281,241],"tags":[],"class_list":["post-19180","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-area-cancer","category-innovacion","category-programa-de-mecanismos-moleculares-y-terapia-experimental-en-oncologia-oncobell","category-sarcoma"],"publishpress_future_action":{"enabled":false,"date":"2024-12-29 12:16:01","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/19180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=19180"}],"version-history":[{"count":2,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/19180\/revisions"}],"predecessor-version":[{"id":19183,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/19180\/revisions\/19183"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/19181"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=19180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=19180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=19180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}